Understand the source comparison
Peptide Purity Levels: Quality Grade Comparison
Not all purity percentages perform identically in research settings. This table outlines the synthesis characteristics, typical impurity profiles, and appropriate research applications for each purity grade. 95–96% Standard solid-phase synthesis, single RP-HPL
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Not all purity percentages perform identically in research settings. This table outlines the synthesis characteristics, typical impurity profiles, and appropriate research applications for each purity grade.
- 95–96%
- Standard solid-phase synthesis, single RP-HPLC purification
- 4–5% deletion peptides, truncated sequences, incomplete side-chain deprotection
- Preliminary screening, non-binding studies, method development where mechanism isn't critical
- 70–80%
- Acceptable for optimization work but not for dose-response or receptor studies—impurities interfere with binding assays
- 97–98%
- Solid-phase synthesis with optimized coupling, dual RP-HPLC purification passes
- 2–3% deletion peptides, trace substitution analogs, residual protecting groups
- Receptor binding assays, cell culture, dose-response studies, publishable research
- Baseline (100%)
- Minimum threshold for reproducible mechanistic research—this is the standard for peer-reviewed peptide pharmacology
- 99%+
- Pharmaceutical-grade synthesis, multiple purification cycles, MS validation
- <1% enantiomers, positional isomers, trace reagent carryover—no significant deletion peptides
- Clinical-grade formulation, long-term stability studies, regulatory submissions
- 140–160%
- Necessary for formulation development and GMP production but overkill for most laboratory research—98% delivers equivalent results in binding studies
- The practical difference between 95% and 98% purity isn't linear—it's the elimination of specific impurity classes that interfere with receptor pharmacology. A peptide at 95% purity doesn't deliver 95% of the intended effect; it delivers unpredictable results because deletion peptides occupy receptors without activating them. For research-grade applications involving compounds like Sermorelin or CJC-1295, 98% is the reliability threshold.